OncoSec Medical Names Former Advaxis Exec O’Conner as CEO

15:26 EST 8 Nov 2017 | Xconomy

OncoSec Medical (NASDAQ: ONCS) has named former Advaxis (NASDAQ: ADXS) CEO Daniel J. O’Conner to take over as chief executive at the San Diego-based company, which has been developing technology to enhance the delivery and uptake of its anti-tumor drug therapies. O’Conner resigned in July from Advaxis, a cancer immunotherapy biotech in Princeton, NJ, and […]

Original Article: OncoSec Medical Names Former Advaxis Exec O’Conner as CEO


More From BioPortfolio on "OncoSec Medical Names Former Advaxis Exec O’Conner as CEO"

Quick Search


Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Allergies Automimmune Disease Human Papillomavirus (HPV) Immunology Vaccine Immunology is the study of immunity and the defence mechanisms of the body. A greater understanding of immunology is needed to develop vaccines, understand ...